loadpatents
name:-0.038496971130371
name:-0.015220165252686
name:-0.0022280216217041
Chartash; Elliot K. Patent Filings

Chartash; Elliot K.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Chartash; Elliot K..The latest application filed is for "dosing regimen of anti-tigit antibody for treatment of cancer".

Company Profile
2.15.38
  • Chartash; Elliot K. - Basking Ridge NJ
  • Chartash; Elliot K. - Randolph NJ
  • Chartash; Elliot K. - Marietta GA
  • Chartash; Elliot K. - Baskin Ridge NJ
  • Chartash; Elliot K. - Brooklyn NY
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Dosing Regimen Of Anti-tigit Antibody For Treatment Of Cancer
App 20210403557 - Cai; Mingmei ;   et al.
2021-12-30
Multiple-variable Dose Regimen For Treating Tnfalpha-related Disorders
App 20210347874 - Hoffman; Rebecca S. ;   et al.
2021-11-11
Dosing Regimen Of Anti-lag3 Antibody And Combination Therapy With Anti-pd-1 Antibody For Treating Cancer
App 20210347889 - Abraham; Anson Kunjachan ;   et al.
2021-11-11
Combination Therapy Of A Pd-1 Antagonist And Lag3 Antagonist For Treating Patients With Non-microsatellite Instability-high Or Proficient Mismatch Repair Colorectal Cancer
App 20210317214 - Chartash; Elliot K. ;   et al.
2021-10-14
Multiple-variable Dose Regimen For Treating Tnfalpha-related Disorders
App 20200017580 - Hoffman; Rebecca S. ;   et al.
2020-01-16
Multiple-variable Dose Regimen For Treating Tnfalpha-related Disorders
App 20170022271 - Hoffman; Rebecca S. ;   et al.
2017-01-26
Use of TNFalpha Inhibitor
App 20160376360 - Hoffman; Rebecca S. ;   et al.
2016-12-29
Use of TNF.alpha. inhibitor
Grant 9,512,216 - Hoffman , et al. December 6, 2
2016-12-06
Multiple-variable dose regimen for treating idiopathic inflammatory bowel disease
Grant 9,499,615 - Hoffman , et al. November 22, 2
2016-11-22
Multiple-variable Dose Regimen For Treating Idiopathic Inflammatory Bowel Disease
App 20160185849 - Hoffman; Rebecca S. ;   et al.
2016-06-30
Treatment Of Tnf-alpha Related Disorders
App 20150368335 - Banerjee; Subhashis ;   et al.
2015-12-24
Multiple-variable dose regimen for treating idiopathic inflammatory bowel disease
Grant 9,187,559 - Hoffman , et al. November 17, 2
2015-11-17
Use Of Tnfalpha Inhibitor For Treatment Of Psoriatic Arthritis
App 20150218269 - Hoffman; Rebecca S. ;   et al.
2015-08-06
Use of TNFalpha Inhibitor for Treatment of Psoriasis
App 20150218268 - Hoffman; Rebecca S. ;   et al.
2015-08-06
Use of TNF.alpha. inhibitor for treatment of psoriasis
Grant 9,090,689 - Hoffman , et al. July 28, 2
2015-07-28
Use of TNF.alpha. inhibitor for treatment of psoriatic arthritis
Grant 9,085,620 - Hoffman , et al. July 21, 2
2015-07-21
Multiple-variable Dose Regimen For Treating Tnfalpha-related Disorders
App 20150175690 - Hoffman; Rebecca S. ;   et al.
2015-06-25
Multiple-variable dose regimen for treating idiopathic inflammatory bowel disease
Grant 9,061,005 - Hoffman , et al. June 23, 2
2015-06-23
Use of TNF.alpha. inhibitor for treatment of psoriasis
Grant 8,986,693 - Hoffman , et al. March 24, 2
2015-03-24
Use of TNFAlpha Inhibitor for Treatment of Psoriasis
App 20150071938 - Hoffman; Rebecca S. ;   et al.
2015-03-12
Uses and Compositions for Treatment of Psoriasis
App 20150050216 - Willian; Mary Kaye ;   et al.
2015-02-19
Use of TNF-alpha inhibitor for treatment of psoriasis
Grant 8,906,373 - Banerjee , et al. December 9, 2
2014-12-09
Multiple-variable dose regimen for treating TNF.alpha.-related disorders
Grant 8,889,136 - Hoffman , et al. November 18, 2
2014-11-18
Treatment Of Tnfalpha Related Disorders
App 20140286939 - Banerjee; Subhashis ;   et al.
2014-09-25
Treatment Of Tnfalpha Related Disorders
App 20140286940 - Banerjee; Subhashis ;   et al.
2014-09-25
Treatment Of Tnfalpha Related Disorders
App 20140286941 - Banerjee; Subhashis ;   et al.
2014-09-25
Methods For Treating Psoriasis
App 20140079714 - Valdes; Joaquin Mario ;   et al.
2014-03-20
Methods for treating psoriasis using antibodies that bind to the P40 subunit of IL-12 and/or IL-23
Grant 8,557,239 - Valdes , et al. October 15, 2
2013-10-15
Treatment Of Juvenile Rheumatoid Arthritis (jra)
App 20130243786 - Banerjee; Subhashis ;   et al.
2013-09-19
Multiple-variable dose regimen for treating TNFa-related disorders
App 20130122011 - Hoffman; Rebecca S. ;   et al.
2013-05-16
Methods For Treating Psoriasis
App 20120189637 - Valdes; Joaquin Mario ;   et al.
2012-07-26
Methods For Treating Psoriasis
App 20110206680 - VALDES; JOAQUIN MARIO ;   et al.
2011-08-25
Methods For Treating Psoriasis
App 20100297143 - Chartash; Elliot K. ;   et al.
2010-11-25
Methods of treating plaque psoriasis
Grant 7,776,331 - Chartash , et al. August 17, 2
2010-08-17
Multiple-variable dose regimen for treating TNFa-related disorders
App 20090304682 - Hoffman; Rebecca S. ;   et al.
2009-12-10
Treatment of Anemia Using TNFalpha Inhibitors
App 20080193466 - Banerjee; Subhashis ;   et al.
2008-08-14
Treatment of respiratory syncytial virus (RSV) infection
App 20060083741 - Hoffman; Rebecca S. ;   et al.
2006-04-20
Multiple-variable dose regimen for treating TNFalpha-related disorders
App 20060009385 - Hoffman; Rebecca S. ;   et al.
2006-01-12
Treatment of skin and nail disorders using TNFalpha inhibitors
App 20040219142 - Banerjee, Subhashis ;   et al.
2004-11-04
Treatment of metabolic disorders using TNFalpha inhibitors
App 20040151722 - Banerjee, Subhashis ;   et al.
2004-08-05
Treatment of pain using TNFalpha inhibitors
App 20040136990 - Banerjee, Subhashis ;   et al.
2004-07-15
Treatment of anemia using TNFalpha inhibitors
App 20040136991 - Banerjee, Subhashis ;   et al.
2004-07-15
Treatment of coronary disorders using TNFalpha inhibitors
App 20040126373 - Banerjee, Subhashis ;   et al.
2004-07-01
Treatment of TNFalpha related disorders
App 20040126372 - Banerjee, Subhashis ;   et al.
2004-07-01
Method for forming electrically conductive paths
Grant 4,159,414 - Suh , et al. June 26, 1
1979-06-26

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed